Doctorats Honoris Causa 2021 - Institut de Recherche Expérimentale et Clinique (IREC/UCLouvain)

Published in the journal : July 2021 Category : Doctorats Honoris Causa 2021

Summary :

On 19 May, the Health Sciences Sector of UCLouvain awarded its highest distinction to 3 personalities of the medical community for their major contribution, Professor Bruno Crestani (University of Paris and Hôpital Bichat, France); Professor Amit Nathwani (University College London and Royal Free Hospital, UK) and Professor Marc Pfeffer (Harvard University and Brigham and Women's Hospital, USA). At this virtual ceremony, the contributions of these renowned researchers in understanding the pathophysiology of pulmonary fibrosis, the development of gene therapy for the treatment of haemophilia and the role of enzyme conversion inhibition in myocardial infarction were presented and honoured. This is a summary of these scientific achievements by exceptional doctors written by the sponsors from the pneumology and haematology division and the cardiovascular department of the Cliniques universitaires Saint-Luc.

Key Words

Doctor Honoris Causa, pulmonary fibrosis, gene therapy, haemophilia, enzyme conversion, myocardial infarction